Key facts
- Notable investors include Zeno Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for BrainQuant
- ·The full record, as it builds
Funding rounds
No funding rounds for BrainQuant are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BrainQuant
Developer of medical imaging technology designed for non-invasive brain blood flow measurement purposes. The company's platform utilizes arterial spin labeling techniques that do not require radioactive contrast agents, enabling healthcare professionals to detect cerebral blood flow and potentially serve as a surrogate for established imaging methods while reducing patient exposure to radiation.
- Sector
- Healthcare
- HQ
- Geneva, Switzerland
- Founded
- 2024
- Employees
- 3
- Website
- brainquant.ch/
- Ownership
- Privately Held (backing)
BrainQuant doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BrainQuant shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BrainQuant in its N-PORT filings yet. We sweep new filings monthly.